Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Mucosal inflammation
ADR ID BADD_A02864
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.06      Mucosal findings abnormal
08.01.06.002      Mucosal inflammation
Description An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY). [MeSH]
MedDRA Code 10028116
MeSH ID D052016
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Inflammation mucous membrane | Mucosal inflammation | Mucosal inflammation NOS | Mucosal sores | Mucositis | Mucositis NOS | Mucositides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00474Cisplatin0.006111%
BADD_D00479Cladribine--
BADD_D00495Clofarabine0.000168%
BADD_D00535Crizotinib0.000604%
BADD_D00544Cyclo-upup--
BADD_D00549Cyclophosphamide--
BADD_D00560Cytarabine0.002720%
BADD_D00561Cytarabine hydrochloride--
BADD_D00571Dactinomycin0.000112%
BADD_D00589Dasatinib--
BADD_D00590Daunorubicin--
BADD_D00592Daunorubicin hydrochloride--
BADD_D00593Decitabine0.000112%
BADD_D00623Dexamethasone0.000436%
BADD_D00628Dexlansoprazole--
BADD_D00652Dichlorphenamide0.000392%
BADD_D00699Docetaxel--
BADD_D00723Doxorubicin0.005182%
BADD_D00784Epirubicin0.000168%
BADD_D00785Epirubicin hydrochloride--
BADD_D00798Eribulin0.001007%
BADD_D00799Eribulin mesylate--
BADD_D00800Erlotinib0.000750%
BADD_D00853Etophos--
BADD_D00854Etoposide0.000448%
BADD_D00855Etoposide phosphate--
BADD_D00858Everolimus0.012353%
BADD_D00879Fentanyl--
BADD_D00880Fentanyl citrate--
BADD_D00897Filgrastim--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 6 Pages